FUTURA GREAT TOE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a literature report with the FDA on 2015-12-04 for FUTURA GREAT TOE manufactured by Tornier Inc..

Event Text Entries

[32739084] This is the initial report submitted regarding this surgical event and medical device. Report based on literature: a retrospective review of the primus first mtp joint double-stemmed silicone implant. Lawrence br, thuen e. Foot ankle spec. 2013 apr;6(2):94-100. Doi: 10. 1177/1938640012470715 http://www. Ncbi. Nlm. Nih. Gov/pubmed/23291555.
Patient Sequence No: 1, Text Type: N, H10


[32739085] As stated in the abstract of the article: "implant arthroplasty has been a surgical alternative for correction of hallux rigidus for many decades. A study is presented reviewing the authors' experience using the (tornier/futura) primus double-stemmed silicone implant. A total of 144 patients representing 201 implants were identified and invited to participate in the study. The postoperative period ranged from 32 to 108 months, with an average of 66. 4 months. Chart review was performed on all cases. This review revealed that there were 2 implants that had been removed, each for reasons other than implant breakdown. Several indications in addition to hallux rigidus were found, including hallux valgus with arthritis, geriatric bunion, rheumatoid arthritis, and iatrogenic and traumatic arthritis. The outcomes are presented for all patients, with additional breakdown by their indication for surgery. In all, 54 patients involving 70 implants responded and were clinically evaluated. This study included a visual analogue scale, foot and ankle (vas fa) patient outcome and satisfaction questionnaire, clinical examination, and x-ray evaluation. Patients with hallux rigidus had an average postoperative american orthopaedic foot and ankle society (aofas) score of 88. 2, and those with hallux valgus with arthritis had an average score of 88. 6. The average aofas score for all patients was 87. 4. The average vas patient satisfaction for all patients was 8. 5 (with 10 being highest satisfaction). Implant arthroplasty continues to be a viable alternative for surgical correction of hallux rigidus as well as other degenerative conditions of the first mtp joint. This procedure is particularly effective in older, less-active patients with lower functional demand. "
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004983210-2015-00074
MDR Report Key5268301
Report SourceLITERATURE
Date Received2015-12-04
Date of Report2014-12-02
Date of Event2013-04-01
Date Mfgr Received2014-12-02
Date Added to Maude2015-12-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDUSTIN SMITH
Manufacturer Street10801 NESBIT AVE SOUTH
Manufacturer CityBLOOMINGTON MN 55437
Manufacturer CountryUS
Manufacturer Postal55437
Manufacturer Phone9529217121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFUTURA GREAT TOE
Generic NameFLEXIBLE GREAT TOE IMPLANT
Product CodeKWH
Date Received2015-12-04
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTORNIER INC.
Manufacturer Address10801 NESBIT AVENUE SOUTH BLOOMINGTON MN 55437 US 55437


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2015-12-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.